Showing results (111-120 of 123) with videos related to
Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|August 28, 2025
Multinational validation of distant metastasis velocity as a post-progression prognostic score in patients with oligometastatic cancer treated with metastasis-directed stereotactic body radiotherapyJonas Willmann, Sarah Baker, Hanbo Chen, et al.Environmental Research|June 21, 2023
Anthropometric measures and arsenic methylation among pregnant women in rural northern BangladeshTyler J S Smith, Ana Navas-Acien, Sarah Baker, et al.JAMA Oncology|September 29, 2022
Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer: Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical TrialRobert Olson, Will Jiang, Mitchell Liu, et al.Journal of Clinical Epidemiology|March 10, 2021
The methodological quality is insufficient in clinical practice guidelines in the context of COVID-19: systematic reviewTanja A Stamm, Margaret R Andrews, Erika Mosor, et al.BMC Oral Health|July 10, 2021
Selective Caries Removal in Permanent Teeth (SCRiPT) for the treatment of deep carious lesions: a randomised controlled clinical trial in primary careJan E Clarkson, Craig R Ramsay, David Ricketts, et al.International Journal of Radiation Oncology, Biology, Physics|April 11, 2025
Evaluating Toxicity and Interaction Outcomes of Systemic Therapy and Stereotactic Ablative Radiation Therapy for Oligometastatic Disease: A Secondary Analysis of the Phase 2 SABR-5 TrialAiden Kooyman, Jee Suk Chang, Mitchell Liu, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2023
Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trialReno Eufemon Cereno, Benjamin Mou, Sarah Baker, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 15, 2026
Five-year follow-up of the SABR-5 trial: primary toxicity analysis of stereotactic ablative radiotherapy for up to five oligometastasesRobert Olson, Mitchell Liu, Alanah Bergman, et al.BMJ Open|January 4, 2025
Micronutrient dose response (MiNDR) study among women of reproductive age and pregnant women in rural Bangladesh: study protocol for double-blind, randomised, controlled trialsTowfida Jahan Siddiqua, Kerry J Schulze, Sm Tafsir Hasan, et al.International Journal of Radiation Oncology, Biology, Physics|January 14, 2024
Upfront Versus Delayed Systemic Therapy in Patients With Oligometastatic Cancer Treated With SABR in the Phase 2 SABR-5 TrialSarah Baker, Linden Lechner, Mitchell Liu, et al.Pageof 13